Trigone Pharma is a clinical stage pharmaceutical company developing safe and effective local treatments for urinary tract diseases.
Using our highly innovative delivery system for sustained release of drugs into the urinary bladder, the localized therapy acts continuously for up to several weeks, a revolution in urology.
Trigone Pharma aims to restore the quality of life for patients suffering from bladder diseases with clear unmet medical need. The first product in development, for the treatment of Interstitial Cystitis / Bladder Pain Syndrome (IC/BPS), is in clinical trials. The second product in development, for the treatment for BCG-Refractory Non-Muscle Invasive Bladder Cancer (NMIBC) is in preclinical stage.
Company Details
- Employees
- 4
- Founded
- -
- Address
- 15 Hatidahar Street, Raanana,israel
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.trigonepharma.com
- HQ
- Raanana
Trigone Pharma Questions
Trigone Pharma's website is http://www.trigonepharma.com
Trigone Pharma's LinkedIn profile is https://il.linkedin.com/company/trigone-pharma
Trigone Pharma has
4 employees.
View email and phone details for 4
employees at Trigone Pharma.
Trigone Pharma's industry is
Pharmaceutical Manufacturing
Trigone Pharma's top competitors are
Pertech Embedded Solutions,
Modulight Biotherapeutics,
Amrita Therapeutics,
Onecell Medical Ltd,
Vallon Pharmaceuticals,
Enducloud,
Rebio,
Teva Pharmaceuticals,
Clinical Site,
Immunsys, Inc..
Trigone Pharma's categories are Pharmaceutical Manufacturing
Trigone Pharma's founding year is 2020
